MCID: SPN042
MIFTS: 43

Spinal Cord Ependymoma malady

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Spinal Cord Ependymoma

Aliases & Descriptions for Spinal Cord Ependymoma:

Name: Spinal Cord Ependymoma 12 52 14
Ependymal Neoplasm of the Spinal Cord 12
Ependymoma of Spinal Cord 69

Classifications:



External Ids:

Disease Ontology 12 DOID:5503
NCIt 47 C3875
SNOMED-CT 64 254949006
UMLS 69 C0238432

Summaries for Spinal Cord Ependymoma

Disease Ontology : 12 A spinal cord glioma that has material basis in cells linking the spinal cord central canal.

MalaCards based summary : Spinal Cord Ependymoma, also known as ependymal neoplasm of the spinal cord, is related to adult spinal cord ependymoma and multiple endocrine neoplasia 1, and has symptoms including motor manifestations and sensory manifestations. An important gene associated with Spinal Cord Ependymoma is NF2 (Neurofibromin 2), and among its related pathways/superpathways are Glioma and Neuroscience. The drugs Dacarbazine and Temozolomide have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, and related phenotypes are Decreased sensitivity to paclitaxel and Increased proliferation

Related Diseases for Spinal Cord Ependymoma

Diseases in the Spinal Cord Ependymoma family:

Adult Spinal Cord Ependymoma

Diseases related to Spinal Cord Ependymoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 45)
id Related Disease Score Top Affiliating Genes
1 adult spinal cord ependymoma 12.1
2 multiple endocrine neoplasia 1 11.0
3 ependymoma 10.6
4 watson syndrome 10.2 NF1 NF2
5 nemaline myopathy 10.2 GFAP HOXB13 RBM10
6 mixed epithelial stromal tumour 10.2 EPB41 GFAP NF2
7 epilepsy, familial focal, with variable foci 10.2 EPB41L3 NF1 NF2
8 melanotic neurilemmoma 10.2 GFAP JAG1 NF2
9 primary familial brain calcification 10.2 NF2 PTEN
10 cervical adenoid cystic carcinoma 10.2 GFAP NF1
11 jejunal somatostatinoma 10.2 GFAP NF1 NF2
12 pediatric cns embryonal cell carcinoma 10.2 GFAP NF2
13 esophageal adenosquamous carcinoma 10.2 GFAP HOXB13 NF2 RBM10
14 monckeberg arteriosclerosis 10.2 GFAP NF1 NF2
15 pharynx cancer 10.1 GFAP NF1 NF2
16 epimetaphyseal dysplasia cataract 10.1 GFAP MEN1 NF2
17 anorexia nervosa 1 10.1 NF2 PTEN
18 breast squamous cell carcinoma 10.1 EPB41L3 GFAP NF2 RBFOX3
19 c-p angle neurinoma 10.1 GFAP NF1 NF2
20 bronchitis 10.1 GFAP NF2
21 central nervous system sarcoma 10.1 GFAP NF1 RBFOX3
22 aneurysm of sinus of valsalva 10.1 GFAP NF2 PTEN
23 dysgerminoma of ovary 10.1 GFAP MEN1 NF2 RBFOX3
24 endocrine organ benign neoplasm 10.1 MEN1 NF1 NF2
25 epidermal appendage tumor 10.1 GFAP PTEN RBFOX3
26 epidural abscess 10.1 NF1 NF2 PTEN
27 autosomal genetic disease 10.0 MEN1 NF1 NF2
28 erythrocytosis, familial, 2 10.0 MEN1 NF1 RASSF1
29 neurofibromatosis 10.0
30 pleomorphic xanthoastrocytoma 10.0 GFAP HOXB13 MTOR NF2 RBFOX3
31 t-cell large granular lymphocyte leukemia 10.0 MEN1 NF1 NF2 PTEN
32 bronchial mucus gland adenoma 9.9 GFAP PTEN
33 ovarian brenner tumor 9.9 AQP1 MTOR PTEN RASSF1
34 focal cortical dysplasia, taylor balloon cell type 9.9 GFAP MTOR NF1 PTEN
35 tetanus neonatorum 9.9 GFAP MTOR NF1 PTEN
36 orofaciodigital syndrome iv 9.8 EPB41L3 GFAP MEN1 NF1 NF2 PTEN
37 hydrocephalus 9.7
38 cervical dystonia 9.7
39 neurogenic bladder 9.7
40 cervicitis 9.7
41 syringomyelia 9.7
42 myxopapillary ependymoma 9.7
43 dystonia 9.7
44 paraplegia 9.7
45 pineal dysgerminoma 7.8 AQP1 CD1A ENSG00000250424 EPB41 EPB41L3 EPHB3

Graphical network of the top 20 diseases related to Spinal Cord Ependymoma:



Diseases related to Spinal Cord Ependymoma

Symptoms & Phenotypes for Spinal Cord Ependymoma

UMLS symptoms related to Spinal Cord Ependymoma:


motor manifestations, sensory manifestations

GenomeRNAi Phenotypes related to Spinal Cord Ependymoma according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased sensitivity to paclitaxel GR00112-A-0 8.96 NF1 PTEN
2 Increased proliferation GR00094-A 8.62 MEN1 NF2

MGI Mouse Phenotypes related to Spinal Cord Ependymoma:

44 (show all 17)
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.3 PTEN RASSF1 EPB41L3 EPHB3 GFAP HOXB13
2 endocrine/exocrine gland MP:0005379 10.29 MTOR NF1 NF2 NOTCH1 PTEN RASSF1
3 mortality/aging MP:0010768 10.28 AQP1 EPB41 EPB41L3 EPHB3 GFAP HIC1
4 cardiovascular system MP:0005385 10.27 AQP1 GFAP JAG1 MEN1 MTOR NF1
5 growth/size/body region MP:0005378 10.27 NF1 NF2 NOTCH1 PTEN VCAN AQP1
6 homeostasis/metabolism MP:0005376 10.23 NF2 NOTCH1 PTEN RASSF1 VCAN AQP1
7 embryo MP:0005380 10.22 HIC1 HOXB13 JAG1 MEN1 MTOR NF1
8 digestive/alimentary MP:0005381 10.19 EPHB3 GFAP HIC1 JAG1 MEN1 NF1
9 nervous system MP:0003631 10.17 AQP1 EPB41L3 EPHB3 GFAP HIC1 HOXB13
10 craniofacial MP:0005382 10.09 EPHB3 HIC1 JAG1 MEN1 NF1 NF2
11 liver/biliary system MP:0005370 10.03 RASSF1 NF1 NF2 NOTCH1 PTEN EPB41
12 hearing/vestibular/ear MP:0005377 10.02 AQP1 EPHB3 HIC1 JAG1 NF1 NF2
13 normal MP:0002873 10 RBM10 VCAN EPB41L3 GFAP HIC1 JAG1
14 neoplasm MP:0002006 9.97 EPB41L3 HIC1 MEN1 NF1 NF2 NOTCH1
15 renal/urinary system MP:0005367 9.81 AQP1 EPB41 EPHB3 JAG1 MTOR NF1
16 skeleton MP:0005390 9.65 AQP1 HIC1 HOXB13 JAG1 MTOR NF1
17 vision/eye MP:0005391 9.23 AQP1 EPHB3 GFAP JAG1 NF1 NF2

Drugs & Therapeutics for Spinal Cord Ependymoma

Drugs for Spinal Cord Ependymoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 130)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dacarbazine Approved, Investigational Phase 2,Phase 1 4342-03-4 5351166
2
Temozolomide Approved, Investigational Phase 2,Phase 1 85622-93-1 5394
3
Bevacizumab Approved, Investigational Phase 2 216974-75-3
4
Irinotecan Approved, Investigational Phase 2 97682-44-5, 100286-90-6 60838
5
Carboplatin Approved Phase 2,Phase 1 41575-94-4 10339178 498142 38904
6
Tamoxifen Approved Phase 2 10540-29-1 2733526
7
Topotecan Approved, Investigational Phase 2 119413-54-6, 123948-87-8 60700
8
Menthol Approved Phase 1, Phase 2 2216-51-5 16666
9
Phenylacetic acid Approved Phase 2 103-82-2 23690424 999
10
Cyproheptadine Approved Phase 2 129-03-3 2913
11
Histamine Approved, Investigational Phase 2 75614-87-8, 51-45-6 774
12
Megestrol acetate Approved, Vet_approved Phase 2 595-33-5 11683
13
Cisplatin Approved Phase 2,Phase 1 15663-27-1 84093 441203 2767
14
Cyclophosphamide Approved, Investigational Phase 2,Phase 1 50-18-0, 6055-19-2 2907
15
Etoposide Approved Phase 2,Phase 1 33419-42-0 36462
16
Vincristine Approved, Investigational Phase 2,Phase 1 2068-78-2, 57-22-7 5978
17
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
18
Vinblastine Approved Phase 2 865-21-4 13342 241903
19
Crizotinib Approved Phase 1, Phase 2 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
20
Dasatinib Approved, Investigational Phase 1, Phase 2 302962-49-8 3062316
21
Ifosfamide Approved Phase 1, Phase 2 3778-73-2 3690
22
Mechlorethamine Approved Phase 1, Phase 2 51-75-2 4033
23
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
24
leucovorin Approved, Nutraceutical Phase 2 58-05-9 54575, 6560146 143
25
Lapatinib Approved March 2007, Investigational Phase 2 231277-92-2, 388082-78-8 208908 9941095
26
Camptothecin Experimental Phase 2 7689-03-4
27 Alkylating Agents Phase 2,Phase 1
28 Antineoplastic Agents, Alkylating Phase 2,Phase 1
29 Protein Kinase Inhibitors Phase 2,Phase 1
30 Angiogenesis Inhibitors Phase 2
31 Angiogenesis Modulating Agents Phase 2
32 Antibodies Phase 2
33 Antibodies, Monoclonal Phase 2
34 Antineoplastic Agents, Phytogenic Phase 2,Phase 1
35 Deoxyglucose Phase 2
36 Endothelial Growth Factors Phase 2
37 Fluorides Phase 2
38 Fluorodeoxyglucose F18 Phase 2
39 Immunoglobulin G Phase 2
40 Immunoglobulins Phase 2
41 Mitogens Phase 2
42 Radiopharmaceuticals Phase 2
43 topoisomerase I inhibitors Phase 2
44 Topoisomerase Inhibitors Phase 2,Phase 1
45 Antineoplastic Agents, Hormonal Phase 2,Phase 1
46 Bone Density Conservation Agents Phase 2
47 Estrogen Antagonists Phase 2
48 Estrogen Receptor Modulators Phase 2
49 Estrogens Phase 2
50 Hormone Antagonists Phase 2,Phase 1

Interventional clinical trials:

(show all 29)
id Name Status NCT ID Phase
1 Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma Unknown status NCT00826241 Phase 2
2 Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma Completed NCT00381797 Phase 2
3 Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors Completed NCT00541138 Phase 2
4 A Phase I/II Study of the Photon Radiosurgery System Completed NCT00179907 Phase 1, Phase 2
5 Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors Completed NCT00006450 Phase 2
6 Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Completed NCT00973739 Phase 2
7 Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Completed NCT00066248 Phase 2
8 Carboplatin and Bevacizumab for Recurrent Ependymoma Recruiting NCT01295944 Phase 2
9 Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors Recruiting NCT03095248 Phase 2
10 Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma Active, not recruiting NCT00602667 Phase 2
11 Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Active, not recruiting NCT00939770 Phase 1, Phase 2
12 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2
13 Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers Not yet recruiting NCT03173950 Phase 2
14 Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Completed NCT01076530 Phase 1
15 Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors Completed NCT00003141 Phase 1
16 AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Completed NCT00326664 Phase 1
17 Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma Completed NCT00363272 Phase 1
18 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Completed NCT00053963 Phase 1
19 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Completed NCT00946335 Phase 1
20 Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors Completed NCT00107458 Phase 1
21 SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors Completed NCT00015899 Phase 1
22 PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors Completed NCT01158300 Phase 1
23 Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Terminated NCT01088763 Phase 1
24 MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer Terminated NCT00572182 Phase 1
25 Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment Withdrawn NCT00458744 Phase 1
26 Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer Unknown status NCT00349024
27 Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics) Recruiting NCT02013297
28 Natural History Study of Patients With Neurofibromatosis Type 2 Active, not recruiting NCT00598351
29 Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain Active, not recruiting NCT00452868

Search NIH Clinical Center for Spinal Cord Ependymoma

Genetic Tests for Spinal Cord Ependymoma

Anatomical Context for Spinal Cord Ependymoma

MalaCards organs/tissues related to Spinal Cord Ependymoma:

39
Spinal Cord

Publications for Spinal Cord Ependymoma

Articles related to Spinal Cord Ependymoma:

(show all 41)
id Title Authors Year
1
Spinal cord ependymoma: a review of the literature and case series of ten patients. ( 27154165 )
2016
2
Microsurgical resection of intramedullary spinal cord ependymoma. ( 25175587 )
2014
3
Spinal cord ependymoma presenting with neurological deficits in the setting of trauma. ( 24982562 )
2014
4
Spinal cord ependymoma associated with neurofibromatosis 1 : case report and review of the literature. ( 24570818 )
2014
5
Spinal cord ependymoma in children--results of postoperative radiotherapy. ( 23490267 )
2013
6
Multiple sclerosis coexisting with spinal cord ependymoma: a case report. ( 23126220 )
2012
7
Giant spinal cord ependymoma with CSF spread. ( 23008221 )
2012
8
Cytologic diagnosis of spinal cord ependymoma in cerebrospinal fluid. ( 23547427 )
2012
9
Laser-assisted microsurgical resection of thoracic intramedullary spinal cord ependymoma. ( 26016400 )
2012
10
Surgical technique and outcomes in the treatment of spinal cord ependymomas: part II: myxopapillary ependymoma. ( 21099714 )
2011
11
Clinical analysis of 21 cases of spinal cord ependymoma : positive clinical results of gross total resection. ( 20224707 )
2010
12
TENS and FES for sensory impairment and gait dysfunction following removal of spinal cord ependymoma--a case report. ( 19387998 )
2009
13
Total removal of cervicothoracic intramedullary 160-mm-long spinal cord ependymoma: a rare case report. ( 21686716 )
2009
14
Outcome predictors in the management of spinal cord ependymoma. ( 16865377 )
2007
15
Subtle clinical signs of a spinal cord ependymoma at the cervicothoracic level in an adult: a case report. ( 17549184 )
2006
16
Surgical and radiotherapy treatment of a spinal cord ependymoma in a dog. ( 16498832 )
2006
17
Spinal cord ependymoma: radical surgical resection and outcome. ( 12879876 )
2003
18
Spinal cord ependymoma: radical surgical resection and outcome. ( 12383361 )
2002
19
Etoposide for recurrent spinal cord ependymoma. ( 11971113 )
2002
20
Special feature: pathological case of the month. Diagnosis and discussion: neurofibromatosis 2 with bilateral vestibular schwannomas and spinal cord ependymoma. ( 10980805 )
2000
21
Spinal cord ependymoma presenting with acute paraplegia due to tumoral bleeding. ( 11105838 )
2000
22
Diagnosis of spinal cord ependymoma and astrocytic tumours with magnetic resonance imaging. ( 10833579 )
1999
23
Surgical outcome of intramedullary spinal cord ependymoma. ( 10352743 )
1999
24
Lipidized (foamy) tumor cells in a spinal cord ependymoma with collagenous metaplasia. ( 9560021 )
1998
25
Spinal cord ependymoma: a positron emission tomographic study with (11C-methyl)-L-methionine. ( 8773278 )
1996
26
Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. ( 8805149 )
1996
27
Giant spinal cord ependymoma in a child. Case report. ( 8913964 )
1996
28
Cervical dystonia due to spinal cord ependymoma: involvement of cervical cord segments in the pathogenesis of dystonia. ( 7565833 )
1995
29
Papilloedema and hydrocephalus in spinal cord ependymoma. ( 8199121 )
1994
30
The pathogenesis of syringomyelia in spinal cord ependymoma. ( 7889696 )
1994
31
Intramedullary abscess associated with a spinal cord ependymoma: case report. ( 1738441 )
1992
32
Postoperative radiotherapy in the management of spinal cord ependymoma. ( 2013772 )
1991
33
Spinal cord ependymoma in two young dogs. ( 3051647 )
1988
34
A case of malignant spinal cord ependymoma in association with a duplication of part of the long arm of chromosome 12. ( 3989836 )
1985
35
Thoracic spinal cord ependymoma presenting with ejaculatory failure. Case report. ( 7054411 )
1982
36
Flaccid neurogenic bladder as a presenting symptom of spinal cord ependymoma. ( 513236 )
1979
37
Spinal cord ependymoma in a dog. ( 245206 )
1977
38
Rapid arteriovenous shunting in a spinal cord ependymoma. Case report. ( 1271096 )
1976
39
A huge intramedullary spinal cord ependymoma with complete recovery following total excision. ( 1238917 )
1975
40
Repeated "occult" spinal subarachnoid hemorrhage and spinal cord ependymoma. ( 4854114 )
1974
41
Rupture of spinal cord ependymoma. Case report. ( 4743575 )
1973

Variations for Spinal Cord Ependymoma

Expression for Spinal Cord Ependymoma

Search GEO for disease gene expression data for Spinal Cord Ependymoma.

Pathways for Spinal Cord Ependymoma

GO Terms for Spinal Cord Ependymoma

Cellular components related to Spinal Cord Ependymoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 apical plasma membrane GO:0016324 9.56 AQP1 JAG1 NOTCH1 PTEN
2 apical part of cell GO:0045177 9.33 AQP1 JAG1 NF2
3 extrinsic component of membrane GO:0019898 9.13 EPB41 EPB41L3 NF2
4 adherens junction GO:0005912 8.8 JAG1 NF2 NOTCH1

Biological processes related to Spinal Cord Ependymoma according to GeneCards Suite gene sharing:

(show all 25)
id Name GO ID Score Top Affiliating Genes
1 regulation of cell proliferation GO:0042127 9.8 JAG1 NF1 NF2 NOTCH1
2 cellular response to hypoxia GO:0071456 9.79 AQP1 MTOR PTEN
3 negative regulation of cell migration GO:0030336 9.79 NF1 NF2 PTEN
4 wound healing GO:0042060 9.77 AQP1 MTOR NF1
5 regulation of GTPase activity GO:0043087 9.72 EPHB3 MTOR NF1
6 negative regulation of MAPK cascade GO:0043409 9.62 NF1 NF2
7 dendritic spine morphogenesis GO:0060997 9.61 EPHB3 PTEN
8 negative regulation of cell-matrix adhesion GO:0001953 9.6 NF1 NF2
9 negative regulation of cell-substrate adhesion GO:0010812 9.58 MEN1 NOTCH1
10 ammonium transmembrane transport GO:0072488 9.58 AQP1 ENSG00000250424
11 negative regulation of protein phosphorylation GO:0001933 9.58 MEN1 MTOR PTEN
12 negative regulation of stem cell differentiation GO:2000737 9.57 JAG1 NOTCH1
13 regulation of synaptic transmission, GABAergic GO:0032228 9.56 NF1 PTEN
14 brain development GO:0007420 9.55 MEN1 MTOR NF1 NF2 NOTCH1
15 negative regulation of oligodendrocyte differentiation GO:0048715 9.54 NF1 NOTCH1
16 response to muramyl dipeptide GO:0032495 9.52 JAG1 NOTCH1
17 negative regulation of cell size GO:0045792 9.51 MTOR PTEN
18 forebrain morphogenesis GO:0048853 9.48 NF1 PTEN
19 cardiac septum morphogenesis GO:0060411 9.46 JAG1 NOTCH1
20 pulmonary valve morphogenesis GO:0003184 9.43 JAG1 NOTCH1
21 Notch signaling involved in heart development GO:0061314 9.37 JAG1 NOTCH1
22 angiogenesis GO:0001525 9.35 EPHB3 HOXB13 JAG1 NOTCH1 PTEN
23 distal tubule development GO:0072017 9.32 JAG1 NOTCH1
24 carbon dioxide transmembrane transport GO:0035378 9.26 AQP1 ENSG00000250424
25 negative regulation of cell proliferation GO:0008285 9.1 MEN1 NF1 NF2 NOTCH1 PTEN RBM10

Molecular functions related to Spinal Cord Ependymoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 structural constituent of cytoskeleton GO:0005200 9.5 EPB41 EPB41L3 GFAP
2 water channel activity GO:0015250 9.26 AQP1 ENSG00000250424
3 ammonium transmembrane transporter activity GO:0008519 9.16 AQP1 ENSG00000250424
4 cytoskeletal protein binding GO:0008092 9.13 EPB41 EPB41L3 NF2
5 carbon dioxide transmembrane transporter activity GO:0035379 8.62 AQP1 ENSG00000250424

Sources for Spinal Cord Ependymoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....